BioMarin rises amid speculation Pfizer might outbid Shire
Shares in BioMarin Pharmaceutical (Nasdaq: BMRN) climbed 4% yesterday, 7 April, amid market chatter of a potential bid for the California-based biopharma company from Pfizer (LON: PFZ), The Daily Mail reported. New York-based drugs giant Pfizer is rumoured to be prepared to outbid any approach the Ireland-headquartered pharmaco Shire (LON: SHP) might make, the market report said.
Daily Mail